Jonathan Reiner is a Cardiology physician affiliated with George Washington University Hospital. OpenAlex indexes 86 publications with 2,659 citations (h-index 22); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2150 Pennsylvania Ave NW
Washington, DC 200373201
Telephone
202-741-2222Provider last certified this registry record 28 Dec 2021.
Clinical trials
- Genotypic and Phenotypic Correlates of Resistance to Aspirin
Sponsor: George Washington University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
26 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20258 payments
- Terumo Medical CorporationProgram year20252 payments
- Amgen Inc.Program year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
87.1%Statin23.6%Atorvastatin Calcium63%Rosuvastatin Calcium37%Part D≥53 patientsBeta blocker19.5%Metoprolol Succinate63%Metoprolol Tartrate20%Carvedilol17%Part D≥43 patients+ 12 more classes in this area
Blood & clotting
10.2%P2Y12 inhibitor5.5%Clopidogrel100%Part D≥20 patientsFactor Xa inhibitor4.7%Eliquis64%Xarelto37%Part D<11 patientsMetabolism & gastrointestinal
2.8%SGLT2 inhibitor2.8%Jardiance100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- RNAseq profiling of blood from patients with coronary artery disease: Signature of a T cell imbalance
Journal of Molecular and Cellular Cardiology Plus
2023 - RNA sequencing of blood in coronary artery disease: involvement of regulatory T cell imbalance
BMC Medical Genomics
2021 - The evolving role of coronary CT angiography in Acute Coronary Syndromes
Journal of cardiovascular computed tomography
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Catherine Bollard, MD
George Washington University Hospital
Roberta Debiasi, MD
George Washington University Hospital
Adelaide Robb, MD
George Washington University Hospital
Gurusher Panjrath, MD
George Washington University Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”